Home > NRC Library > ADAMS Public Documents

August 7 letter from Exubrion Therapeutics regarding treatment of dogs with Synovetin OA

Accession Number: ML19221B309

Date Released: Friday, August 9, 2019

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML19221B310 - Letter from Exubrion Therapeutics re: Resolution of USNRC Concerns Regarding Treatment of Dogs with Synovetin OA Containing Sn-117m dated August 7, 2019. (2 page(s), 8/7/2019)
• ML19221B311 - Owner Interview Checklist. (3 page(s), 8/9/2019)
• ML19221B312 - Veterinary Release Instruction Guidance. (1 page(s), 8/9/2019)